XML 34 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
OPERATING ACTIVITIES:    
Net income $ 449 $ 461
Adjustments to net income:    
Depreciation and amortization 926 836
Gain (loss) on disposal and sale of business interests (43) 4
Impairment expense 355 358
Deferred income tax expense (benefit), net of tax credit transfers 423 (102)
Emissions Allowance Expense 144 211
Loss on realized/unrealized foreign currency 92 184
Other 81 118
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (576) 16
(Increase) decrease in inventory 58 253
(Increase) decrease in prepaid expenses and other current assets 120 76
(Increase) decrease in other assets 177 (4)
Increase (decrease) in accounts payable and other current liabilities 34 (187)
Increase (decrease) in income tax payables, net and other tax payables (514) (67)
Increase (decrease) in other liabilities 132 73
Net cash provided by operating activities 1,664 2,309
INVESTING ACTIVITIES:    
Capital expenditures (5,665) (5,295)
Payments to Acquire Businesses and Interest in Affiliates 79 311
Proceeds from Divestiture of Businesses and Interests in Affiliates 11 98
Sale of short-term investments 731 1,002
Purchase of short-term investments (725) (764)
Contributions and loans to equity affiliates (71) (147)
Payments to Acquire Intangible Assets (157) (161)
Other investing (134) (95)
Net cash used in investing activities (6,089) (5,673)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities 5,652 3,939
Repayments under the revolving credit facilities (4,051) (2,730)
Proceeds from (Repayments of) Commercial Paper 611 604
Issuance of recourse debt 950 1,400
Issuance of non-recourse debt 5,199 1,784
Repayments of non-recourse debt (3,311) (1,262)
Payments for financing fees (88) (76)
Purchases under supplier financing arrangements (1,211) (1,307)
Repayments of obligations under supplier financing arrangements 1,412 1,099
Distributions to noncontrolling interests (165) (173)
Contributions from noncontrolling interests 137 63
Sales to Noncontrolling Interests 869 371
Dividends paid on AES common stock (361) (333)
Payments for financed capital expenditures (29) (8)
Other financing (25) (47)
Net cash provided by financing activities 5,187 3,740
Effect of exchange rate changes on cash, cash equivalents and restricted cash (47) (108)
Net Cash Change Of Discontinued And Held For Sale Businesses (146) (20)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 569 248
Cash, cash equivalents and restricted cash, beginning 1,990 2,087
Cash, cash equivalents and restricted cash, ending 2,559 2,335
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 1,103 735
Cash payments for income taxes, net of refunds 270 267
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Noncash or Part Noncash Divestiture, Amount of Consideration Received 14 215
Lease Obligation Incurred 240 187
Conversion of Stock, Amount Converted 838 0
Liability derecognized due to sale of assets 273  
Non-cash contributions from noncontrolling interests 213 60
Other current assets, net of allowance of $0 and $14, respectively 1,460  
Loss (gain) on realized/unrealized derivatives (194) $ 79
Warrior Run    
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Liability derecognized due to sale of assets $ 260